https://wiki.tiffa.net/w/index.php?action=history&feed=atom&title=Translations%3AGlucagon-like_peptide-1%2F24%2FenTranslations:Glucagon-like peptide-1/24/en - Revision history2026-09-14T23:23:46ZRevision history for this page on the wikiMediaWiki 1.43.0https://wiki.tiffa.net/w/index.php?title=Translations:Glucagon-like_peptide-1/24/en&diff=127251&oldid=prevFuzzyBot: Importing a new version from external source2024-03-11T00:48:14Z<p>Importing a new version from external source</p>
<p><b>New page</b></p><div>== Research history ==<br />
In the 1980s, [[Svetlana Mojsov]] worked on the identification of GLP-1 at [[Massachusetts General Hospital]], where she was head of a peptide synthesis facility. To try to identify whether a specific fragment of GLP-q was an incretin, Mojsov created an incretin-antibody and developed ways to track its presence. She identified that a stretch of 31 amino acids in the GLP-1 was an incretin. Mosjov and her collaborators [[Daniel J. Drucker]] and Habener showed that small quantities of lab-synthesized GLP-1 could trigger insulin.</div>FuzzyBot